DKA is most commonly seen in patients with type 1 diabetes mellitus (DM) but may also occur in patients with type 2 diabetes, particularly in those treated with insulin or sodium-glucose cotransporter-2 (SGLT-2) inhibitors, where mechanisms such as relative insulin deficiency and increased ketogenesis contribute to risk [2]. Here, SLC5A2 is linked to diabetes mellitus.